rss
Gut 2003;52:1500-1504 doi:10.1136/gut.52.10.1500
  • Liver

Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy

  1. C Skipper1,
  2. J M Guy2,
  3. J Parkes3,
  4. P Roderick3,
  5. W M Rosenberg4
  1. 1HMP Parkhurst, Isle of Wight, UK
  2. 2Liver Group, Division of Infection, Inflammation, and Repair, University of Southampton, Southampton, UK
  3. 3Health Services Research Unit, Liver Epidemiology Group, Division of Community Clinical Sciences, University of Southampton, Southampton, UK
  4. 4Liver Group, Division of Infection, Inflammation, and Repair, University of Southampton, and Health Services Research Unit, Liver Epidemiology Group, Division of Community Clinical Sciences, University of Southampton, Southampton, UK
  1. Correspondence to:
    Dr W M C Rosenberg, Liver Group, Division of Infection, Inflammation, and Repair, Mailpoint 811, Level D South Block, Southampton General Hospital, Tremona Rd, Southampton, Hampshire SO16 6YD, UK;
    wmr{at}soton.ac.uk
  • Accepted 9 June 2003

Abstract

Background: Hepatitis C virus (HCV) infection is a major public health problem recognised by the UK National Strategy that proposes that a care pathway for assessment, diagnosis, and treatment be established in all prisons, integrated within managed clinical networks. A prison sentence provides the opportunity to focus on traditionally hard to reach patients.

Aims: To evaluate the prevalence of HCV infection in a UK prison cluster and to assess the effectiveness of a prison outreach service for hepatitis C.

Subjects: Male prisoners.

Methods: A nurse specialist led clinic within a cluster of adult prisons was established, offering health education on hepatitis C, advice on harm minimisation, and HCV testing. Infected prisoners were offered access to a care pathway leading to treatment. Outcome measures were uptake of the service, and diagnosis and treatment of hepatitis C.

Results: A total of 8.5% of 1618 prisoners accepted testing: 30% had active infection with HCV. Most were ineligible for treatment due to psychiatric illness or did not receive treatment for logistic reasons. Injecting drug use was the major risk factor in all cases. Only 7% of HCV polymerase chain amplification positive inmates received treatment in prison.

Conclusion: There is a large pool of HCV infected prisoners at risk of complications, constituting a source of infection during their sentence and after discharge. A prison outreach clinic and care pathway was perceived as effective in delivering health education, reducing the burden on prison and hospital services. It provided an opportunity for intervention but had a limited effect in eradicating HCV in prisoners and it remains unclear how this might be achieved.

Footnotes

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.